In 2021 and 2022, the United States witnessed a significant rise in cancer deaths among individuals aged 15 to 44. This increase was notably higher than expected, with rates climbing by 5.6% and 7.9% respectively, compared to a smaller increase of 1.7% in 2020. This information comes from a recent study conducted by Phinance Technologies.
The study, based on data from the CDC, highlights a concerning trend. It reveals a marked increase in deaths due to neoplasms, starting from 2020 and escalating sharply in the following two years. The magnitude of this surge in 2021 and 2022 is statistically significant, pointing to extreme events in the pattern of cancer mortality.
David Wiseman, PhD, a co-author of the study with 86 publications to his credit, suggests that this alarming trend could be attributed to a novel phenomenon, COVID-19, or possibly the COVID-19 vaccine. However, the exact cause remains an open question.
The research indicates a new phenomenon leading to a rise in deaths from neoplasms among the 15 to 44 age group in the US. The authors propose that this could be due to an unexpected increase in the incidence of rapidly growing fatal cancers or a decrease in survival rates among existing cancer cases. They also consider the impact of reduced access to cancer screening and treatment during the pandemic as a potential factor.
Despite the careful analysis, the study does not conclusively determine the duration of illness before death, leaving open the possibility of so-called ‘turbo cancers’ – a term for rapidly developing cancers, though this concept has been widely debated.
In a bold statement on social media, researcher “Ethical Skeptic” highlights a strong correlation between cancer incidence & mortality and the rollout of the Covid mRNA vaccine, suggesting a significant impact of the vaccine on cancer trends.
Ed Dowd, a principal at Phinance, echoed these concerns, noting the sudden growth in the cancer treatment sector. He points out that both cancer treatments and disabilities have seen inflection points coinciding with the mRNA vaccine rollouts in 2021.
The data presents worrying trends that demand attention and honest exploration by the CDC and other agencies. Yet, the public’s call for answers, encapsulated in the hashtag #WhereIsTheCDC, has yet to be addressed satisfactorily.
Amid these concerns, Pfizer and several other companies are ramping up their investments in cancer drugs, post-COVID, indicating a shift in focus towards addressing this growing health crisis.
Phinance Technologies continues to lead self-funded deep dives into pandemic data, uncovering trends in deaths, disabilities, and other health-related issues that have gone unnoticed. Their work is crucial in shedding light on these pressing health concerns, and they welcome support from those who are interested in furthering this important research.